Your browser doesn't support javascript.
loading
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.
Godot, Véronique; Tcherakian, Colas; Gil, Laurine; Cervera-Marzal, Iñaki; Li, Guangming; Cheng, Liang; Ortonne, Nicolas; Lelièvre, Jean-Daniel; Pantaleo, Giuseppe; Fenwick, Craig; Centlivre, Mireille; Mouquet, Hugo; Cardinaud, Sylvain; Zurawski, Sandra M; Zurawski, Gerard; Milpied, Pierre; Su, Lishan; Lévy, Yves.
Afiliação
  • Godot V; Vaccine Research Institute, Creteil, France.
  • Tcherakian C; Inserm U955, Equipe 16, Créteil, France.
  • Gil L; Hôpital Foch, Service de Pneumologie, Suresnes, France.
  • Cervera-Marzal I; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Li G; Aix Marseille Université, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
  • Cheng L; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Ortonne N; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Lelièvre JD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Pantaleo G; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Fenwick C; AP-HP, Hôpital Henri-Mondor Albert-Chenevier, Service d'Anatomopathologie, Créteil, France.
  • Centlivre M; Vaccine Research Institute, Creteil, France.
  • Mouquet H; Inserm U955, Equipe 16, Créteil, France.
  • Cardinaud S; AP-HP, Hôpital Henri-Mondor Albert-Chenevier, Service d'Immunologie Clinique et Maladies Infectieuses, Créteil, France.
  • Zurawski SM; Vaccine Research Institute, Creteil, France.
  • Zurawski G; Service of Immunology and Allergy Lausanne University Hospital, Lausanne, Switzerland.
  • Milpied P; Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Su L; Vaccine Research Institute, Creteil, France.
  • Lévy Y; Service of Immunology and Allergy Lausanne University Hospital, Lausanne, Switzerland.
PLoS Pathog ; 16(11): e1009025, 2020 11.
Article em En | MEDLINE | ID: mdl-33253297
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Antígenos CD40 / Receptor Toll-Like 9 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Antígenos CD40 / Receptor Toll-Like 9 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França